Perrigo Company plc (NYSE:PRGO) Stock Has Consensus Price Target of $19.33 According to Brokerages

Shares of Perrigo Company plc (NYSE:PRGO) have earned a consensus rating of “Hold” from the six research firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $19.33.

A number of analysts have issued reports on the stock. Weiss Ratings upgraded shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. Wall Street Zen lowered shares of Perrigo from a “strong-buy” rating to a “buy” rating in a research note on Sunday, September 27th.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Sound Income Strategies LLC raised its stake in shares of Perrigo by 3.9% in the 3rd quarter. Sound Income Strategies LLC now owns 1,615,467 shares of the company’s stock valued at $23,424,000 after acquiring an additional 60,838 shares in the last quarter. O Keefe Stevens Advisory Inc. lifted its holdings in Perrigo by 9.6% in the 3rd quarter. O Keefe Stevens Advisory Inc. now owns 915,885 shares of the company’s stock worth $13,518,000 after purchasing an additional 80,230 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Perrigo by 30.8% in the 3rd quarter. GAMMA Investing LLC now owns 19,270 shares of the company’s stock worth $284,000 after purchasing an additional 4,537 shares during the last quarter. Venture Visionary Partners LLC boosted its position in Perrigo by 13.3% during the third quarter. Venture Visionary Partners LLC now owns 185,199 shares of the company’s stock worth $2,734,000 after purchasing an additional 21,691 shares during the period. Finally, Parrish Capital LLC boosted its position in Perrigo by 19.2% during the third quarter. Parrish Capital LLC now owns 40,408 shares of the company’s stock worth $596,000 after purchasing an additional 6,512 shares during the period. Institutional investors and hedge funds own 95.91% of the company’s stock.

Perrigo Stock Down 0.4%

Shares of PRGO traded down $0.06 during midday trading on Tuesday, reaching $15.39. 163,195 shares of the stock were exchanged, compared to its average volume of 3,072,874. The company has a market cap of $2.14 billion, a price-to-earnings ratio of -1.23, a P/E/G ratio of 1.72 and a beta of 0.69. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. Perrigo has a 12-month low of $9.23 and a 12-month high of $22.02. The firm has a 50 day simple moving average of $13.97 and a 200-day simple moving average of $11.90.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the previous year, the business posted ($0.06) EPS. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Research analysts forecast that Perrigo will post 2.18 EPS for the current year.

Perrigo Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were given a $0.29 dividend. The ex-dividend date of this dividend was Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 7.5%. Perrigo’s payout ratio is currently -9.27%.

About Perrigo

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products.